nandrolone has been researched along with atropine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Degtiareva, II; Solodova, EV | 1 |
| Degtiareva, II | 1 |
| Dediulescu, DF; Dediulescu, L | 1 |
6 other study(ies) available for nandrolone and atropine
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[Possible ways of correcting disorders of the amino acid content of the blood serum and gastric mucosa during treatment of peptic ulcer].
Topics: Amino Acids; Atropine; Drug Therapy, Combination; Gastric Mucosa; Hexamethonium Compounds; Humans; Nandrolone; Nandrolone Decanoate; Papaverine; Peptic Ulcer | 1984 |
[Changes in protein metabolism during the treatment of peptic ulcer with cholinergic blockaders in combination with stimulators of protein synthesis and amino acid mixtures].
Topics: Adult; Amino Acids; Atropine; Desoxycorticosterone; Drug Therapy, Combination; Duodenal Ulcer; Female; Hexamethonium Compounds; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Papaverine; Parasympatholytics; Protein Biosynthesis; Stimulation, Chemical; Stomach Ulcer; Uracil | 1980 |
[Study of cytotoxic and antiviral effects of some eye drops].
Topics: Analgesics, Opioid; Androgens; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Atropine; Dexamethasone; Drug Therapy, Combination; Ethylmorphine; Glucocorticoids; Humans; Indomethacin; Keratitis, Herpetic; Nandrolone; Neomycin; Ophthalmic Solutions; Tobramycin; Treatment Outcome | 2008 |